ISTH/LinkedIn
Oct 3, 2025, 12:30
ISTH: Advancing Hemophilia Treatment Today and Tomorrow
International Society on Thrombosis and Haemostasis (ISTH) shared a post on LinkedIn:
“New CME opportunity! The hemophilia treatment landscape is rapidly evolving — are you up to date?
Our latest expert-led module, Updates in FVIIa Mimetics: Advancing Hemophilia Treatment Today and Tomorrow, is designed for hematology care teams including physicians, NPs, PAs, nurses and pharmacists.
What you’ll get:
- Key insights into emerging therapies
- Clinical trial updates
- Best practices to individualize patient care”
Start learning today here
Stay updated with Hemostasis Today.
-
Jun 15, 2026, 10:49Aurelio Maggio: How Is The Treatment Landscape Of Thrombotic Thrombocytopenic Purpura Evolving?
-
Jun 15, 2026, 10:49Marek Mráz: A Landmark EHA 2026 for Our Lab
-
Jun 15, 2026, 10:32Magnus Ek: Operational Excellence in Delivering Seamless Access for 17,000 Delegates at EHA 2026 Congress
-
Jun 15, 2026, 10:15Carol Bewick: Why the Global Community Makes EHA 2026 Unforgettable
-
Jun 15, 2026, 10:07Habib Bennaceur: Driving Haemoglobinopathies Progress Across Multiple Clinical Programmes At EHA 2026
-
Jun 14, 2026, 22:49Cihan Ay: From First Oral Presentation to Pro and Con Debate – A 20-Year EHA Journey
-
Jun 14, 2026, 19:54Tareq Abadl: What Happens If You Transfuse the Wrong Blood Group?
-
Jun 14, 2026, 19:46Amber Yates: Stretching Scientific Muscles in Areas of Hematology – Day 2 at EHA 2026
-
Jun 14, 2026, 19:41Peter Loffelhardt: Thousands of People Coming in – Second Day at EHA 2026